NEW YORK (
CHANGE IN RATINGS
was upgraded at Wells Fargo from Market Perform to Outperform. Company should become independent from the government over the next year, Wells Fargo said.
was downgraded at Keybanc from Buy to Hold. Valuation call, Keybanc said.
was initiated with a Neutral rating, Piper Jaffray said. Valuation call, based on a $129 price target, Piper Jaffray said.
was upgraded at Morgan Stanley from Underweight to Equal-weight. Estimates were also boosted, following recent acquisitions, Morgan Stanley said.
was upgraded to Hold at TheStreet Ratings.
Fortune Brands Home
was initiated with a Neutral rating at Credit Suisse. $22 price target. Margins are improving as spending rebounds, Credit Suisse said.
was initiated with a Buy rating at Ladenburg Thalmann. $60 price target. Water demand is increasing in developing regions, Ladenburg Thalmann said.
was downgraded at FBR Capital Markets from Market Perform to Underperform. $9 price target. Consensus earnings expectations appear too high, FBR said.
was initiated with an Overweight rating at JP Morgan. Strong energy focus and technology-driven competitive advantages, JP Morgan said.
was downgraded at Jefferies to Hold from Buy. Likely slow market uptake, Jefferies said.
was upgraded at Citigroup to Buy from Neutral. $55 price target. Retail trends should be encouraging to investors, Citi said.
was initiated with a Buy rating at Citigroup. $60 price target. Xyrem is the key value driver in the near term, Citi said.
was downgraded at JP Morgan from Overweight to Neutral. Valuation call, based on a $52.50 price target, JP Morgan said.
was initiated with an Overweight rating at JP Morgan. $45 price target. Transition story already in progress, JP Morgan said.
was initiated with a Neutral rating at JP Morgan. $14.50 price target. Upside potential is substantial, but so are the risks, JP Morgan said.
was upgraded to Buy at TheStreet Ratings.
was initiated with a Market Perform rating at Wells Fargo. Valuation call, as capital markets have failed to meaningfully recovered, Wells Fargo said.
was downgraded at Auriga USA to Hold. $51 price target. Stock is already pricing in potential approval of Relistor and Crofelemer, Auriga USA said.
Stock Comments / EPS Changes
estimates, target were raised at Credit Suisse. Share are now seen reaching $30. Estimates were also increased, following the patent deal with
, Credit Suisse said. Neutral rating.
Crown Castle International Corp.
target was raised at Oppenheimer. Shares are now seen reaching $62. Continued 4G buildouts continue to be very positive, Oppenheimer said. Outperform rating.
was removed from the Analyst Focus List at JP Morgan. $29 price target. Strong YTD performance and tougher box office comps, JP Morgan said.
price target was lowered at UBS to $62. Preparing for Phillips 66 spinoff, UBS said. Sell rating.
price target was boosted at Morgan Stanley. Shares now seen reaching $23. Recent datapoints suggest a gradual improvement in capital spending, Morgan Stanley said. Overweight rating.
price target was lowered at Jefferies. Shares are now seen reaching $69. APSC final decision in the AEP SWEPCO proceeding may serve as a precedent, Jefferies said. Hold rating.
estimates, price target were raised at Guggenheim. Shares are now seen reaching $13. Estimates were also increased, given the company's new guidance, Guggenheim said. Neutral rating.
The Greenbrier Companies
numbers were lowered at Jefferies. Shares are now seen reaching $20. Estimates were also lowered on lower-than-expected manufacturing gross margins, Jefferies said. Hold rating.
numbers were raised at UBS. Shares are now seen reaching $825. New products and initiatives are gaining traction, UBS said. Buy rating.
price target was raised at Morgan Stanley. Shares are now seen reaching $27. Industry spending should improve during the Spring, Morgan Stanley said. Overweight rating.
price target was raised at Citigroup to $50. Midstream to drive multiple expansion, Citigroup said. Buy rating.
numbers were raised at Oppenheimer. Shares are now seen reaching $75. Estimates were also raised on solid quarter and outlook, Oppenheimer said. Outperform rating.
Qualcomm numbers were raised at UBS. Shares are now seen reaching $80. Estimates were also increased on upside from LTE leadership, UBS said.
was added to the Top Picks Live list at Citigroup. $31 price target. Set to benefit from the availability of a wide variety of discounted crudes at its Gulf Coast refineries, Citigroup said.
price target was boosted at Bank of Merrill/Merrill Lynch to $30. Now model an 80% likelihood of Qnexa being approved in 2012, BofA/Merrill said. Buy rating.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on
This article was written by a staff member of TheStreet.